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Abstract
Background: There is a worldwide variation in the prevalence and subtype distribution of juvenile idiopathic
arthritis (JIA) which may be affected by ethnicity and genetic factors. The purpose of this study is to determine
the prevalence, subtype distribution and characteristic features of JIA among Omani children and to compare our
results with other ethnic populations worldwide.
Methods: A population-based, multicenter study among pediatric rheumatology clinics in the Sultanate over a
10 year period between 2004–2013. The diagnosis of JIA and identification of JIA subtypes was based on the ILAR
2004 revised criteria. The hospital charts of these patients were retrospectively reviewed and information was
collected. All patients were screened for uveitis by an ophthalmologist using slit lamp examination during regular
follow up visits.
Results: The study included a total of 107 cases of JIA in Oman over the study period. Among the 107 patients,
71 % (n = 77) were girls with a female:male ratio of 2.5:1. The mean age of disease onset was 6.85 ± 3.86 years
(range 1–13years) while the mean disease duration of 4.8 ± 2.9 years (range 1–11 years). The incidence of JIA
was estimated at 2/100,000 with a prevalence of JIA of 20/100,000. The prevalence of JIA in girls was 28/100,000
while the prevalence in boys was 12/100,000. According to disease distribution, the most frequent subtype
was polyarticular JIA rheumatoid factor negative (39.2 %) followed by oligoarthritis (31.8 %), systemic (17.8 %),
polyarticular JIA rheumatoid factor positive (7.5 %). The unique feature of the Omani cohort is the lack of
occurrence of uveitis.
Conclusions: This is the first epidemiological JIA study conducted in Oman that highlights unique geographical
disease phenotype. Compared to Western counties, there were higher frequency of polyarticular disease and lack of
occurrence of uveitis. Further studies are needed to evaluate the implications of genetic, ethnic and environmental
differences of disease expression.
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Background
Juvenile idiopathic arthritis (JIA) is an inflammatory
disorder characterized by chronic arthritis. It is a clin-
ical diagnosis in a child less than 16 years of age with
arthritis that is defined as swelling or limitation of motion
of the joint accompanied by heat, pain or tenderness
for at least 6 weeks duration with other identifiable
causes of arthritis excluded. JIA has been classified by
the International League of Associations for Rheuma-
tology (ILAR) into seven subtypes including systemic,
oligoarticular, polyarticular rheumatoid factor (RF)
positive and RF negative, enthesitis-related arthritis
(ERA), psoriatic and “other” JIA [1]. The classification
system was developed to identify clinically homogenous
JIA subtypes to facilitate communication regarding
epidemiology, therapeutics and outcomes globally [2].
JIA is the most common rheumatic illness in chil-
dren in the Western world [3]. According to the litera-
ture, oligoarticular JIA (50–60 %), polyarticular JIA
(30–35 %), systemic JIA (10–20 %) and ERA (1–7 %)
are the most common JIA subtypes [2]. However, there
is a worldwide discrepancy in the prevalence and
subtypes distribution of JIA which may be affected by
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ethnicity and genetic factors [3]. There is paucity of
data on epidemiology of JIA in children in Arabs.
Therefore, the purpose of this study was to determine
the prevalence, subtype distribution and characteristic
features of JIA among Omani children and to compare
our results with other ethnic population worldwide.
Methods
We conducted a multicenter study among pediatric
rheumatology clinics in the Sultanate Oman to identify
patients with JIA over a 10-year period from 2004–2013.
All the subjects included in the study were Omani
children <13 years of age, being the cut of limit for the
pediatric age group in most Arabian countries. Patients
who had the signs and symptoms of other arthritis
such as para-/post-infectious arthritis, connective tissue
disorder, systemic vasculitis, malignancy, or metabolic
diseases were excluded from the study after careful
evaluation. The diagnosis of JIA and identification of
subtypes of JIA was based on the ILAR 2004 revised
criteria. Patients whose diagnosis was made prior to the
use of the ILAR criteria were subsequently diagnosed as
having JIA according to the ILAR criteria from a review
of the medical records. All patients fulfilled the ILAR
criteria for diagnosis of JIA at least six months prior to
the inclusion into the study.
The medical records of the pediatric patients were
retrospectively reviewed and information was collected
including date of birth, age, gender, age at diagnosis,
disease duration, joint involvement, JIA onset type and
treatment. Immunological parameters collected included
antinuclear antibodies (ANA), measured by indirect
immunoflorescence and RF as detected by ELISA. Hu-
man leukocyte antigen (HLA) was evaluated on conven-
tional lymphocytotoxicity assay in a few of the patients
who had onset of arthritis after the age of 6 years. ANAs
was considered positive if a titer of ≥1:80 was obtained
on at least 1 clinic visit during the disease course. RF was
considered to be positive when titers were >20 IU/ml. If
only one test of RF was performed, as was the case in
many patients, then the results of this test were used to
assign a JIA subtype rather than apply the subtype
category of “other JIA.” All patients were screened for
uveitis by an ophthalmologist using slit lamp examination
during regular follow up visits at 3, 6 or 12 monthly
intervals as per the pediatric screening recommendation for
uveitis in JIA [4].
The study was approved by Sultan Qaboos University,
College of Medicine Ethics Comittee.
Statistical analysis
Descriptive statistics were used to summarize the data. For
categorical variables, frequencies and percentages were re-
ported. Differences between countries were analyzed using
Pearson’s χ2 test or Fisher’s exact test for cells <5. For
continuous variables, mean and standard deviation were
used to present the data. An a priori two-tailed level of
significance was set 0.05. Statistical were performed using
Stata, version 13.1 (STATA corporation, College Station,
TX, USA).
Results
Over the 10-year study period, 107 cases of JIA in Oman
were identified. Among the 107 patients, 71 % (n = 77)
were girls with a female to male ratio of 2.5:1. The mean
age of disease onset of 6.85 ± 3.86 years (range 1-
13years) with mean disease duration of 4.8 ± 2.9 years
(range 111 years). The incidence of JIA was estimated at
2/100,000 with a prevalence of JIA of 20/100,000. The
prevalence of JIA in girls was 28/100,000 while the
prevalence in boys was 12/100,000.
According to disease distribution, the most frequent
subtype was polyarticular JIA RF negative (39.2 %)
followed by oligoarthritis JIA (31.8 %), systemic JIA
(17.8 %), polyarticular JIA RF positive (7.5 %) and ERA
(3 %) while psoriatic arthritis was detected in 0.9 %
among our patient cohort. There were no patients who
were classified in “others category”. The characteristic
features of JIA subtypes, gender ratio, mean age at onset
and ANA positivity is shown in Table 1. Oligoarticular
JIA and systemic onset JIA had an earlier disease onset
of 5 years than polyarticular JIA with disease onset at
8 years and ERA with mean age of onset at 12 years.
With regards to sex distribution, polyarticular RF + JIA
had the highest female to male ratio compared to both
polyarticular JIA RF negative and oligoarticular JIA.
While systemic onset JIA had equal sex distribution and
patients with ERA were predominately males. Interest-
ingly, patients with polyarticular RF + JIA had the high-
est frequency of positive ANA followed by oligoarticular
and polyarticular RF – JIA. The highest inflammatory
markers at disease onset was observed in patients with
systemic onset JIA and polyarticular RF+ JIA.
The pattern of joint involvement in each subtype is
shown in Table 2. Patients with oligoarticular JIA tended
to have involvement of large joints of the lower limbs
such as knees and ankles. Patients with ERA also had
predominately lower limb involvement with sacroiliac
joints, hip and knees affected in all cases. However the
other JIA subtypes had involvement of both upper and
lower limbs at variable frequencies.
The comparison of JIA subtypes in Oman with different
ethnic populations is shown in Table 3. Systemic onset JIA
was the most prevalent subtypes in Asian countries like
Japan [5] and Arab origin like Saudi Arabia [6] while
oligoarticular JIA subtype was most prevalent in western
countries like Canada [7] and France [8]. However, polyar-
ticular JIA, especially RF -, was most common in patients
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of Arab origin like Kuwait [9], Egypt [10] and Oman
(current study) as well as in patients with African origin as
in Zambia [11] and Nigeria [12].
Extra-articular feature of JIA were predominately seen
in patients with systemic onset JIA which included fever
(100 %), evanescent rash (66 %), generalized lymphaden-
opathy (50 %), hepatosplenomegaly (43 %) and serositis
(34 %). A unique feature of our cohort is the absence of
uveitis despite a 10-year follow up. Treatment modalities
used for these patients included nonsteroidal anti-
inflammatory drugs 97 % (n = 104), prednisolone 74 %
(n = 80), methotrexate 61 % (n = 66) and biologic agents
34 % (n = 37).
Discussion
Sultanate of Oman is an Arab country situated in the
Middle East. It has a unique geographical variation; the
coast is located by the Arabian Sea in the South and East
and the Gulf of Oman on the Northeast. According to
2010 Omani census, the Omani population is estimated
to be 1,957,336 of which 528,480 (27 %) are children
below 14 years of age with equal M: F ratio. We report
the result of a 10-year study, which is the first epidemio-
logical study to be conducted on JIA in Oman.
In our cohort the incidence of JIA was estimated to be
2/100,000 with a prevalence of 20/100,000. Around the
world, there are geographical differences in the epidemi-
ology of JIA with incidence rates that varies from 1.6–23
and prevalence from 3.8–400/100,000 [13]. The variation
in results around the world may be associated with
many reasons. Since classifications have been proposed
and changed over the last decades, differences in data
found with use of certain classifications may reflect
changes due to time rather than real differences. Time
may also have affected the methodological quality of the
studies and how results are presented. Geographical
differences may also be linked with the type of study
which could be clinic-based study or population-based
study and the case ascertainment methods used, which
have varied between accurate systematic health visits
attended and survey-based methods on questionnaires
to health practitioners. Therefore, determining if the
differences reported in the prevalence and incidence are
true differences is difficult because of the heterogeneity
of classification used, time, geographical zone, and meth-
odology used [3].
Ethnic differences in the prevalence of JIA have also
been observed in various populations. As examples, the
prevalence of JIA is less in blacks, Asians, and Indian
ethnicity than in Caucasian children in North America
[14] and is higher in the native populations than among
Caucasians among Canadian children [15]. Furthermore,
in a multiethnic cohort from Toronto, Canada, those
from European descent were associated with a signifi-
cantly increased risk of developing JIA [8]. In addition to
ethnic diversity in epidemiology of disease, there is a
significant differences in JIA subtype distribution around
Table 1 Characteristics of juvenile idiopathic arthritis (JIA) among children in Oman (N = 107)
JIA subtype n (%) Age at onset,
years ± SD
F/M ratio ANA+ (%) Mean ESR,
mm/h
Oligo JIA 34 (31.8 %) 5.3 ± 3.8 3.3/1 32.3 31.3
Poly RF –ve 42 (39.2 %) 8.0 ± 3.5 3.2/1 21.4 43.8
Poly RF + ve 8 (7.5 %) 8.8 ± 3.1 8/1 50 61.8
Systemic 19 (17.8 %) 5.0 ± 3.3 1/1 0 80.6
ERA 3 (2.8 %) 12.0 ± 2.6 0/3 0 62.6
Psoriatic 1 (0.9 %) 11 0/1 0 60
Others 0 (0 %) na na na na
SD standard deviation, F/M female/male, ANA anti-nuclear antibodies, ESR erythrocyte sedimentation rate, Oligo oligoarticular, Poly RF polyarticular rheumatoid factor,
ERA enthesitis-related arthritis, na not available
Table 2 Joint involvement in juvenile idiopathic arthritis (JIA)





Poly RA + ve
(n = 8)




SI 0 0 0 3 1
Hip 2 0 0 4 3
Knee 10 29 8 39 3
Ankle 12 9 7 32 3
MTP 1 1 5 15 0
Spine 0 1 1 6 1
TMJ 0 0 1 2 0
Shoulder 1 1 0 1 0
Elbow 8 1 4 23 0
Wrist 7 3 8 33 0
MCP 1 0 4 20 0
PIP 2 2 4 15 0
DIP 0 0 0 4 0
Oligo oligoarticular, Poly RF polyarticular rheumatoid factor, ERA enthesitis-related
arthritis, SI sacroiliac, MTP metatarsophalangeal joint, TMJ temperomandibular,
MCP metacarpophalangeal joint, PIP proximal interphalangeal joint, DIP distal
interphalangeal joint
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the world. Our study included patients who were Omanis
with no other ethnic background. In our cohort, there was
a relative paucity of oligoarticular disease with a higher
prevalence of polyarticular JIA compared to the Western
countries. The relative rarity of oligoarticular JIA in non-
European populations has also been documented in JIA
patients from Kuwait [9], Turkey [16], Thailand [17], Japan
[5] and South Africa [18] as well as in African American
children in the USA [14].
Oligoarthritis has a striking age at onset distribution
with a peak incidence between 2 and 4 years with a
small proportion of children having the disease onset
after this time [19].
However, in our cohort of patients, the mean age of
disease onset was older at 5.4 ± 3.8 years. In Western
countries, the sex ratio of 5–6:1 is observed in patients
with oligoarticular disease with uveitis, while in our
cohort the sex ratio was 3.3:1 [19]. Therefore, our cohort
has an older age of onset onset and relative paucity of
girls than the Western population. The pattern of joint
involvement in our patients with oligoarticular JIA is
comparable to those reported in the literature as it
predominately affects large joints of the knees (85 %)
and ankles (26 %) [20].
Patients with extended oligarticular JIA had involve-
ment of wrists (8.8 %) and elbows (3 %).
Polyarticular JIA typically has a biphasic age of onset
with an early peak between the ages of 1 and 4 years,
and a later peak at the ages of 6 and 12 years [19]. In
our cohort of polyarticular JIA (n = 50), there was
predominately a late onset peak in the majority of the
children (62 %), while a minority (14 %) had an earlier
onset peak of disease onset. Polyarticular JIA is predom-
inately a disease of girls, the sex ratio of our cohort
matches that reported in the literature 4:1 [19]. The pat-
tern of joint involvement in polyarticular RF – showed
that there was a greater involvement of lower limbs than
upper limbs with knees and ankles affected at 92 and
88 % of the cases while wrists, elbows and small joints
were affected in 78, 55 and 35 % of cases, respectively.
Patients with polyarticular RF+JIA, had equal involve-
ment of both lower and upper limbs with knees and
ankles involved in 100 and 88 %, respectively, while
wrists and elbows were involved in 100 and 50 % cases,
respectively.
Systemic onset JIA characteristic features in our
cohort matched those reported in the literature in terms
of frequency, equal sex distribution and mean onset age
of onset [19]. Any number of joints can be affected at
onset of disease. The pattern of joint involvement in our
patients with systemic onset JIA included involvement of
both upper and lower limbs in a symmetrical distribu-
tion with knees and ankles involved in 52 and 63 % of
cases while elbows and wrists were involved in 42 and
37 % of cases, respectively. Similarly, our cohort of
patients with ERA matched the pattern found worldwide
with predominately a male disease affecting the lower
limbs with relative late childhood onset.
JIA associated uveitis occurs in 10–20 % of all cases
[19]. Typically, uveitis occurs most commonly in young
girls with oligoarticular onset JIA, with ANA positivity
(78 to 90 %) while it occurs in 7–15 % of polyarticular
and rarely in systemic onset variety. The greatest risk for
developing uveitis occurs within the first 2 years after
the onset of JIA, and the risk declines by 7 years after
the onset of arthritis. The unique feature noted in our
cohort of JIA population was the absence of uveitis in-
cluding the oligoarticular JIA subtype characterized with
the following risk features for developing uveitis includ-
ing mean onset of disease at 5.2 years with high female
to male ratio of 3.3:1 and ANA positivity in 32 % of
cases. Perhaps the older age of onset, relative paucity of
girls and relative lack of frequency of positive ANA can
explain the uncommon occurrence of uveitis as a com-
plication in our cohort. Geographical variations in the
incidence of uveitis in JIA have been reported around
the world [21–23]. In a series of 89 JIA patients from
India, there were no cases of uveitis in patients with




















Systemic 17.8 % 54 % 8.9 % 13.6 % 29 % 13.6 % 44 % 14.1 % 7.7 % <0.001
Oligo JIA 31.8 % 21 % 40.3 % 39.8 % 29 % 52.2 % 26 % 32 % 26 % <0.001
Poly JIA 46.7 % 25 % 25.6 % 42 % 29.5 % 30 % 46.1 % 41 % <0.001
Poly RF+ 7.5 % - 0 3.6 % - 8.3 % - 11.5 % 14.1 % 0.006
Poly RF- 39.2 % - 22.4 % 22 % - 21.2 % - 34.6 % 26.9 % 0.001
Psoriatic arthritis 0.9 % - 4.5 % 10.8 % - 0 - 1.3 % 1.3 % <0.001
ERA 2.8 % - 17.9 % 8.8 % - 4.5 % - 6.4 % 23 % 0.002
Undifferentiated - - 1.3 % - - 0.019
Oligo oligoarticular, Poly RF polyarticular rheumatoid factor, ERA enthesitis-related arthritis
Percentages are column percents
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oligoarticular disease with ANA positivity [21]. In a
study in New Zealand, only one of 55 JIA children devel-
oped uveitis [22].
Atypical clinical features of uveitis were described in a
study from Costa Rica with four of the 48 patients with
JIA developing uveitis, and all of them were anti-nuclear
antibodies (ANA) negative and >7 years of age at arth-
ritis onset [23].
This study is not without limitations including its
retrospective nature. Furthermore, this study was also
not fully generalizable as it was hospital- and not-
population based. The patients’ case-mix included all pa-
tients that were referred to a pediatric rheumatology
clinic. However, it may not have included the “milder
cases” that have not been correctly diagnosed and re-
ferred by a general practitioner and paediatrician.
Perhaps, only the more “obvious” polyarticular type of
disease were diagnosed correctly and referred to a ter-
tiary hospital. This could have resulted in underestima-
tion of our parameters due to referral bias. Despite this,
a previous population based cohort study compared with
those from the referral-based cohort, found no signifi-
cant differences with regard to disease duration, fre-
quency of uveitis, subgroup distribution, disease activity,
and number of tender/swollen joints [24]. The other
limitation is recruitment of children with JIA who were
below 13 years of age, and did not include patients up to
16 years which is the defined as JIA according to ILAR
classification because of the government policy on the
cut off age limit in the pediatric population in the
hospitals in Oman; therefore, there was underestimation
of total number of patients.
Conclusion
This is the first epidemiological JIA study conducted in
Oman that highlights unique geographical disease
phenotype. We conclude that the characteristics of JIA
in Omani children with are different from those of
European and North American origin with higher fre-
quency of polyarticular disease and lack of occurrence
of uveitis. Taken together, we suggest that the differ-
ences in immunogenetic background of ethnic groups
may account for the differences in expression of dis-
ease. There is a need for further studies from different
ethnic groups and geographic locations in order to
improve our knowledge about how genetic and envir-
onmental differences affect JIA expression.
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